Investor Relations

Overview

MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

Read More
Webcast ImageWebcast
MyoKardia Inc at the BMO Capital Markets Conference (Replay)
December 12, 2018 at 8:00 a.m. ET
MyoKardia Inc at the BMO Capital Markets Conference
Wednesday, December 12, 2018 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Recent Press Releases

Upcoming Events

There are currently no events scheduled.